Status:
TERMINATED
Pain Relief Investigation of NeuroModulation Therapy in Adult Humans
Lead Sponsor:
Fralex Therapeutics
Collaborating Sponsors:
PharmaNet
Conditions:
Chronic Musculoskeletal Pain
Phase:
PHASE3
Brief Summary
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00253032
Last Update
March 3 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.